Evidence map›Paper›PMID 18095939›Full record

ArticleThe Biochemical journal2008

Human PDE4A8, a novel brain-expressed PDE4 cAMP-specific phosphodiesterase that has undergone rapid evolutionary change.

Kirsty F Mackenzie, Emma C Topping, Bozena Bugaj-Gaweda, Chengjun Deng, York-Fong Cheung, Aileen E Olsen, Cecil R Stockard, Lisa High Mitchell, George S Baillie, William E Grizzle and 4 more

Abstract read
In one paragraph

Article in The Biochemical journal, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  4. Clinical Implication of Phosphodiesterase-4-Inhibition.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Article
  7. mAKAP-a master scaffold for cardiac remodeling.Journal of cardiovascular pharmacology · 2015
    Review
  8. PDE4 as a target for cognition enhancement.Expert opinion on therapeutic targets · 2013
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Kirsty F MackenzieMolecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK.
Emma C Topping
Bozena Bugaj-Gaweda
Chengjun Deng
York-Fong Cheung
Aileen E Olsen
Cecil R Stockard
Lisa High Mitchell
George S Baillie
William E Grizzle
Michael De Vivo
Miles D Houslay
Daguang Wang
Graeme B Bolger
University of Glasgow · GBPhilips (Finland) · FIUniversity of Alabama at Birmingham · USUniversity of Utah · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
BIOMARKER VALIDATION LABORATORIESU24CA086359 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GRIZZLE, WILLIAM E. · 2000 to 2010
$5.1M
REGULATION OF THE CAMP SPECIFIC PHOSPHODIESTERASESR01GM058553 · NIGMS · UNIVERSITY OF UTAH · PI BOLGER, GRAEME B · 1999 to 2003
$1.1M
Intramural NIH HHSMedical Research Council G0600765Medical Research Council G8604010Medical Research Council G9504010NCI NIH HHS 5U24CA086359-08NCI NIH HHS P30 CA013148NCI NIH HHS P30CA13148-36NCI NIH HHS U24 CA086359NIGMS NIH HHS R01 GM058553NIGMS NIH HHS R01-GM58553
6 · The paper itself

Abstract

We have isolated cDNAs encoding PDE4A8 (phosphodiesterase 4 isoform A8), a new human cAMP-specific PDE4 isoform encoded by the PDE4A gene. PDE4A8 has a novel N-terminal region of 85 amino acids that differs from those of the related 'long' PDE4A4, PDE4A10 and PDE4A11 isoforms. The human PDE4A8 N-terminal region has diverged substantially from the corresponding isoforms in the rat and other mammals, consistent with rapid evolutionary change in this region of the protein. When expressed in COS-7 cells, PDE4A8 localized predominantly in the cytosol, but approx. 20% of the enzyme was associated with membrane fractions. Cytosolic PDE4A8 was exquisitely sensitive to inhibition by the prototypical PDE4 inhibitor rolipram (IC(50) of 11+/-1 nM compared with 1600 nM for PDE4A4), but was less sensitive to inhibition by cilomilast (IC(50) of 101+/-7 nM compared with 61 nM for PDE4A4). PDE4A8 mRNA was found to be expressed predominantly in skeletal muscle and brain, a pattern that differs from the tissue expression of other human PDE4 isoforms and also from that of rat PDE4A8. Immunohistochemical analysis showed that PDE4A8 could be detected in discrete regions of human brain, including the cerebellum, spinal cord and cerebral cortex. The unique tissue distribution of PDE4A8, combined with the evolutionary divergence of its N-terminus, suggest that this isoform may have a specific function in regulating cAMP levels in human skeletal muscle and brain.

Indexed as

Evolution, MolecularGene Expression Regulation, EnzymologicAmino Acid SequenceAnimalsBase SequenceBrainChlorocebus aethiopsCOS CellsCyclic AMP-Dependent Protein KinasesCyclic Nucleotide Phosphodiesterases, Type 4DNA, ComplementaryGenome, HumanHumansMolecular Sequence DataNucleotidesOrgan SpecificityCyclic AMP-Dependent Protein KinasesCyclic Nucleotide Phosphodiesterases, Type 4DNA, ComplementaryNucleotidesPDE4A protein, humanRNA, Messenger

Identifiers

PMID18095939
PMCPMC4337886
OpenAlexW2057201113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.